Description: Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics, Bracing & Supports, and Patient Care. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated. Its Bracing & Supports segment provides bracing and supports products, such as supporting devices for spinal, hip, knee, foot, ankle, and hands for therapeutic and preventative purposes; and injury solutions for people recovering from fractures and ligament injuries. The Patient Care segment offers prosthetics for people with lower and upper limb loss or limb difference; and orthotics for neurological, gait, and musculoskeletal conditions. It serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers. The company sells its products through its direct sales networks and distributors. The company was formerly known as Össur hf. and changed its name to Embla Medical hf. in April 2024. Embla Medical hf. was incorporated in 1971 and is headquartered in Reykjavik, Iceland. Embla Medical hf. is a subsidiary of William Demant Invest A/S.
Home Page: www.emblamedical.com
GrjOthAls 1-5
Reykjavik,
Iceland
Phone:
354 515 1300
Officers
| Name | Title |
|---|---|
| Mr. Sveinn Solvason | President & CEO |
| Mr. Ossur Kristinsson | Founder |
| Ms. Gudny Arna Sveinsdottir | Chief Financial Officer |
| Mr. Lukas Marklin | Chief Operating Officer |
| Edda Lara Luovigsdottir | Investor Relations Director |
| Ms. Margret Lara Fridriksdottir | Executive Vice President of People, Strategy & Sustainability |
| Mr. Olafur Gylfason | Executive Vice President of Chronic Solutions |
| Mr. Christian Robinson | President of Americas |
| Ms. Hildur Einarsdottir | Executive Vice President of Research & Development |
Exchange: CO
Country: DK : Denmark
Currency: Danish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 30.5155 |
| Price-to-Book MRQ: | 2.6083 |
| Price-to-Sales TTM: | 15.417 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 4000 |